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Abstract
Background
Current epigenetic research makes frequent use of whole-genome ChIP profiling for determining the
in vivo binding of proteins, e.g. transcription factors and histones, to DNA. Two important and re-
current questions for these large scale analyses are: 1) What is the genomic distribution of a set of
binding sites? and 2) Does this genomic distribution differ significantly from another set of sites?
Findings
We exemplify the functionality of the PinkThing by analysing a ChIP profiling dataset of cohesin
binding sites. We show the subset of cohesin sites with no CTCF binding have a characteristic genomic
distribution different from the set of all cohesin sites.
Conclusions
The PinkThing is a web application for fast and easy analysis of the context of genomic loci, such as
peaks from ChIP profiling experiments. The output of the PinkThing analysis includes: categorisation
of position relative to genes (intronic, exonic, 5’ near, 3’ near 5’ far, 3’ far and distant), distance to
the closest annotated 3’ and 5’ end of genes, direction of transcription of the nearest gene, and the
option to include other genomic elements like ESTs and CpG islands. The PinkThing enables easy
statistical comparison between experiments, i.e. experimental versus background sets, reporting over-
and underrepresentation as well as p-values for all comparisons. Access and use of the PinkThing is
free and open (without registration) to all users via the website: http://pinkthing.cmbi.ru.nl
Findings
Background
Transcription factor (TF) binding sites can be identified in vivo using the emerging technologies for
ChIP profiling such as ChIP-on-chip and ChIP-sequencing. These experiments locate hundreds to tens
of thousands TF binding sites, which subsequently have to be validated and analysed for biological
function. Certain initial analyses of TF binding sites have already become commonplace: mapping of
the binding sites to the genome, detecting closest genes to the binding sites, categorising binding sites by
their position relative to the genes, and the subsequent GO analysis of the genes closest to the binding
sites. The same type of analyses apply to other regions found by ChIP profiling, e.g. with specific
histone modification patterns or DNA hyper- or hypomethylated loci. The PinkThing gathers all these
analyses into one single user-friendly tool, standardises the characterisation of genomic locations, uses
up-to-date ENSEMBL gene annotation, and at the same time enables statistically sound comparisons
at each step of the analysis. Although it is possible to perform similar analysis using bioinformatic
packages like Taverna [1] or Galaxy [2], these packages require installation, initialisation and scripting
(Taverna) or a certain level of statistics skills from the user (e.g. Galaxy). Another more specialised
tool is the HyperBrowser [3], which is based on Galaxy and designed to incorporate functions to query
and correlate annotation along the genome. The versatility of this tool is impressive, but it comes at
the cost of usability. Compared to the PinkThing, the HyperBrowser has a complex interface that takes
time to learn to use efficiently. A more accessible tool is GREAT [4] which provides a web interface for
analysis, with a focus specifically on cis-regulatory regions for human, mouse and zebrafish.
With the PinkThing tool the genomic analyses with statistics are available and ready-to-use directly from
the website by a simple upload of a file containing the coordinates of genomic regions of interest. In
addition, the PinkThing provides the option of supplying an appropriate background distribution to be
used for comparisons, e.g. the set of all binding sites of a ChIP-seq experiment when examining a subset
of these sites. Furthermore, the PinkThing analysis of genomic distributions supports all species that are
annotated in Ensembl. PinkThing has already been successfully used for the analysis of ChIP profiling
data in a wide variety of data, including [5-17].
Approach
Through the PinkThing web page, the user uploads the genomic sites of interest using a standard format
for genomic locations (BED format). PinkThing compares the sites to the Ensembl gene annotation
and optionally to Ensembl CpG islands, ESTs and regulatory features. The initial results include basic
statistics of the genomic distribution of the uploaded positions:
 histograms of distances to the 5’ and the 3’ ends of genes,
 a barplot and a pie chart of the genomic distribution relative to Ensembl genes/CpG islands/ESTs
(Figure 1a).
 a barplot of the genomic distribution.
Figure 1 PinkThing produces graphical output along with the statistics of the genomic distribu-
tions. Three plots and a table produced by the PinkThing comparison of Cohesin sites (background)
versus Cohesin-no-CTCF sites (foreground). a) PinkThing pie chart showing the overall genomic dis-
tribution of cohesin-no-CTCF sites directly upon upload. b) The output of the PinkThing comparison
illustrating the category sizes by ratio of foreground over background, indicating significance by stars
as indicated in Figure 1c. c) Table of statistics for Cohesin-no-CTCF (foreground) versus all Cohesin
sites (background) with the G-test p-value for each genomic category. d) The barplot of category fre-
quencies of the compared distributions, showing the relative frequencies side-by-side. For this analysis
the ‘near’-limit was set to 1000bp and the ‘far’ limit to 3000 bp.
Every output plot is clickable for download of an SVG (Scalable Vector Graphics) version of the plot
for publication. Subsequent analyses can be accessed from the results page and include:
 transcription start sites (TSS) within the surrounding regions,
 the conservation score (GERP [18]) for these regions,
 comparisons to other sets of genomic regions,
 retrieval of the reference DNA sequence for the uploaded regions,
 GO annotation and GO enrichment analysis of the nearest genes (only available for human and
mouse).
As an example, we considered the CTCF (CCCTC binding factor) and cohesin binding sites as deter-
mined using ChIP-seq in a study by Schmidt et al. [19]. In this study, Schmidt et al. also discovered a
subset of cohesin binding sites that did not overlap with CTCF binding sites. Using the PinkThing we
compared the genomic distribution of the set of cohesin sites with the set of cohesin sites not bound by
CTCF (cohesin-no-CTCF sites). We chose the cutoffs for ‘near’ and ‘far’ categories in our analysis to
be 1000bp and 3000bp respectively, to match the categories presented in their paper [19] and examined
PinkThing-determined categorisation and genomic distribution of the sites (Figure 1a). The categorisa-
tion of the subset cohesin-no-CTCF is very informative when viewed in relation to the background set
of all cohesin binding sites: The PinkThing provides the relative sizes of each of the categories for the
two sets of sites (Figure 1b), the Brandt-Snedecor test statistic for comparison of the two distributions,
as well as p-values for whether the differences in distributions are significant per category (Figure 1c)
as well as a barplot showing the frequencies of the two distributions grouped per category (Figure 1d).
The Brandt-Snedecor test indicates that the genomic distribution of cohesin and cohesin-no-CTCF sites
are significantly different (p < 2:2e   16) and the individual category comparison shows the cohesin-
no-CTCF sites are significantly overrepresented in promoter regions (5’ near) and exon regions, and
underrepresented in 3’ regions as compared to the set of all cohesin sites (Figure 1c). The Gene On-
tology (GO) result from the PinkThing (Additional file 1: noCTCF-vs-cohesin.xls) indicates that the
cohesin-no-CTCF binding sites are, relative to all cohesin sites, overrepresented (adjusted p < 10e  3)
in the following GO categories: nucleic acid binding (GO:0003676), transcription regulator activity
(GO:0030528), regulation of metabolic process (GO:0019222) (See Supplementary material: noCTCF-
vs-cohesin-GO.xls). The difference in genomic distributions suggests a difference in function, which
was confirmed by Schmidt et al. who showed that the cohesin-no-CTCF sites are enriched for DNA bind-
ing sites of tissue-specific transcription factors, and further explored this fact in a follow-up study [20].
Methods
Database access
Lookup and data retrieval from the Ensembl database was implemented using the Ensembl Perl API
http://www.ensembl.org/info/docs/api/core/core_tutorial.html.
Statistics
Statistical tests and generation of plots and figures on the PinkThing website are implemented in R
[21] and bioperl [22]. Detailed description of plots and their interpretation is in the PinkThing manual
available from the PinkThing website.
Categorising positions
For each imported locus, PinkThing determines the distance to the closest gene. Positions that fall into
multiple categories are assigned to the highest ranking category in the order: exon, intron, 5’ near, 3’
near, 5’ far, 3’ far and distant. As the surrounding sequence may contain overlapping gene annotations,
the gene annotations are merged such that each position corresponds to a unique genome category.
The limits for “near” and “far” may be chosen by the user, with default values being 5kb and 25kb,
respectively.
Comparison of category distributions
The initial statistical test is the Brandt-Snedecor test for homogeneity of k binomial distributions [23].
The test assumes i) that the observations are independent; ii) that the set chosen as background distri-
bution is at least twice the size as the set chosen as sample distribution and iii) that the k categories
are exhaustive and mutually exclusive. Our implementation of the Brandt-Snedecor test does not test
whether there is an overlap of actual observations in the two sets of the comparison. The test compares
the distribution of observations over categories, indifferent to the identity of the observation. In our
example above we show how we apply the comparison between a set of sites (cohesin binding sites) and
a subset of those sites (cohesin-noCTCF sites), but the test can also be applied to compare two disparate
sets of sites in the genome.
Let n1 and n2 be the total counts for each of the distributions 1 and 2, with n = n1 + n2 and let n2i
and n1i be the counts within category i, then the test statistic is given by Equation 1, and the p-value
obtained by comparing to a 2k 1 distribution. If the distributions are identical, the value of the test will
be 1.
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To determine whether each of the genomic categories is significantly overrepresented, we apply the log
likelihood G-test for independence [24] per category, comparing each category against the union of the
other categories.
GO analysis
The PinkThing uses Ontologizer [25] to perform GO statistics on the set of genes that are closest to the
uploaded set of sites. The output includes both the graphical Ontologizer visualization of overrepre-
sented categories as well as a table with p-values of all terms. The GO statistics can either be calculated
against the whole genome as background or against the genes corresponding to another uploaded set.
Currently the GO ontology analysis is available for human and mouse.
Conclusion
Determination of the annotation context of genomic loci is an indispensable foundation for their func-
tional analysis. To allow distributions of genomic categories to be compared within the same genome
assembly, the implementation of categorisation in PinkThing consistently assigns exactly one category
to any genomic position, thus providing consistent and reproducible analysis. The PinkThing categori-
sation into consistent genomic categories allows the comparison with a background or reference dis-
tribution. This comparison is essential when examining distributions where the categories vary in size
and abundance dependent on the context of the genome (the species) and the experiment (e.g. selecting
for specific genomic elements). PinkThing makes it easy to compare results from a specific experiment
with a chosen background distribution, thus increasing the value and confidence in interpreting results.
PinkThing is a collection of the most common genomic analyses related to genomic context, combined
in a simple point and click web interface. With no prerequisites other than obtaining a dataset, PinkThing
provides easy access to sound statistical analysis of genomic location data.
Availability and requirements
Access and use of the PinkThing is free and open (without registration) to all users via the website:
http://pinkthing.cmbi.ru.nl
 Project name: The PinkThing for analysing ChIP profiling data in their genomic context
 Project home page: http://www.bioinformatics.org/pinkthing/
 Operating systems: Usage of web tool is platform independent, access is available via all major
web browsers at http://pinkthing.cmbi.ru.nl .
 Code repository (SVN): www.bioinformatics.org/svnroot/pinkthing
 License: GNU GPL
The two data sets with cohesin binding sites with and without CTCF are available for download from
the front page of the PinkThing and included with the additional files for this article (Additional file
2: all cohesin binding sites, cohesin.bed; Additional file 3: cohesin binding sites without CTCF,
no_CTCF_cohesin.bed).
To reproduce the results in this paper:
1. Go to http://pinkthing.cmbi.ru.nl and select Ensembl version 53.
2. Then enter the desired cutoff for near and far positions as 1000 and 3000 respectively.
3. Upload the two files one at a time by selecting the file location and click ‘upload and calculate’.
4. To perform the comparison, from the start page of the PinkThing, select the two uploaded files
in the box ‘Compare genomic distributions’, choosing the cohesin sites with no CTCF bind-
ing as the sample file (foreground) and choosing the set of all cohesin binding sites as sample
space(background).
5. Click ‘Compare’ to view the results.
6. To find overrepresented ontologies, from the start page of the PinkThing, select the two uploaded
files in the respected boxes for Sample space (all cohesin binding sites) and sample file (cohesin
binding sites without CTCF) and click Ontologize.
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Additional files
Additional_file_1 as XLS
Additional file 1: noCTCF-vs-cohesin-GO.xls. The Ontologizer result of comparing the cohesin sites
without CTCF (the study set) against the background set of all cohesin sites.
Additional_file_2 as BED
Additional file 2: cohesin.bed. Cohesin binding sites in BED format, as obtained from Schmidt et
al. [19].
Additional_file_3 as BED
Additional file 3: No CTCF cohesin.bed. Sites of cohesin binding with no CTCF binding, as obtained
from Schmidt et al. [19].
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